Pulsenmore Ltd. Ordinary Shares (PLSM) - Net Assets
Based on the latest financial reports, Pulsenmore Ltd. Ordinary Shares (PLSM) has net assets worth $56.31 Million USD as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($100.61 Million) and total liabilities ($44.31 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See Pulsenmore Ltd. Ordinary Shares (PLSM) net asset quality to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $56.31 Million |
| % of Total Assets | 55.97% |
| Annual Growth Rate | 66.1% |
| 5-Year Change | -47.83% |
| 10-Year Change | N/A |
| Growth Volatility | 1089.53 |
Pulsenmore Ltd. Ordinary Shares - Net Assets Trend (2019–2025)
This chart illustrates how Pulsenmore Ltd. Ordinary Shares's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Pulsenmore Ltd. Ordinary Shares (PLSM) market capitalisation.
Annual Net Assets for Pulsenmore Ltd. Ordinary Shares (2019–2025)
The table below shows the annual net assets of Pulsenmore Ltd. Ordinary Shares from 2019 to 2025. Also explore Pulsenmore Ltd. Ordinary Shares (PLSM) equity growth momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $83.09 Million | -19.45% |
| 2024-12-31 | $103.15 Million | -21.08% |
| 2023-12-31 | $130.70 Million | -28.45% |
| 2022-12-31 | $182.67 Million | +14.69% |
| 2021-12-31 | $159.28 Million | +2918.76% |
| 2020-12-31 | $5.28 Million | +33.44% |
| 2019-12-31 | $3.95 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Pulsenmore Ltd. Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 17205940900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.00K | 0.00% |
| Other Comprehensive Income | $10.09 Million | 12.15% |
| Other Components | $256.14 Million | 308.26% |
| Total Equity | $83.09 Million | 100.00% |
Pulsenmore Ltd. Ordinary Shares Competitors by Market Cap
The table below lists competitors of Pulsenmore Ltd. Ordinary Shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Biosynex
PA:ALBIO
|
$15.74 Million |
|
Dataprep Holdings Bhd
KLSE:8338
|
$15.75 Million |
|
Alta Zinc Limited
F:8EE
|
$15.75 Million |
|
Vereinigte Filzfabriken AG
MU:VFF
|
$15.75 Million |
|
Clean Seas Seafood Limited
F:C7S
|
$15.73 Million |
|
Enero Group Ltd
AU:EGG
|
$15.73 Million |
|
123fahrschule SE
DU:123F
|
$15.73 Million |
|
Charm Engine
KO:009310
|
$15.73 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Pulsenmore Ltd. Ordinary Shares's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 96,667,601 to 83,090,000, a change of -13,577,601 (-14.0%).
- Net loss of 15,853,000 reduced equity.
- New share issuances of 25,000 increased equity.
- Other comprehensive income decreased equity by 851,161.
- Other factors increased equity by 3,101,560.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-15.85 Million | -19.08% |
| Share Issuances | $25.00K | +0.03% |
| Other Comprehensive Income | $-851.16K | -1.02% |
| Other Changes | $3.10 Million | +3.73% |
| Total Change | $- | -14.05% |
Book Value vs Market Value Analysis
This analysis compares Pulsenmore Ltd. Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.19x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.77x to 0.19x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.64 | $2.42 | x |
| 2020-12-31 | $0.47 | $2.42 | x |
| 2021-12-31 | $29.96 | $2.42 | x |
| 2022-12-31 | $30.44 | $2.42 | x |
| 2023-12-31 | $20.47 | $2.42 | x |
| 2024-12-31 | $15.09 | $2.42 | x |
| 2025-12-31 | $12.92 | $2.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Pulsenmore Ltd. Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -19.08%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -39.61%
- • Asset Turnover: 0.39x
- • Equity Multiplier: 1.23x
- Recent ROE (-19.08%) is above the historical average (-103.15%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -117.29% | 0.00% | 0.00x | 1.60x | $-5.03 Million |
| 2020 | -475.00% | 0.00% | 0.00x | 3.12x | $-14.03 Million |
| 2021 | -16.67% | -1623.89% | 0.01x | 1.09x | $-40.97 Million |
| 2022 | -11.80% | -204.54% | 0.05x | 1.26x | $-40.03 Million |
| 2023 | -44.29% | -946.46% | 0.03x | 1.36x | $-71.18 Million |
| 2024 | -37.92% | -380.25% | 0.07x | 1.46x | $-46.32 Million |
| 2025 | -19.08% | -39.61% | 0.39x | 1.23x | $-24.16 Million |
Industry Comparison
This section compares Pulsenmore Ltd. Ordinary Shares's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $638,670,729
- Average return on equity (ROE) among peers: -85.75%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Pulsenmore Ltd. Ordinary Shares (PLSM) | $56.31 Million | -117.29% | 0.79x | $15.74 Million |
| Abbott Laboratories (ABT) | $4.40 Billion | 38.41% | 1.14x | $177.76 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $12.40 Million | -202.26% | 2.49x | $11.55 Million |
| Aethlon Medical Inc (AEMD) | $-9.30 Million | 0.00% | 0.00x | $1.11 Million |
| Acutus Medical Inc (AFIB) | $-131.82 Million | 0.00% | 0.00x | $903.35K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $780.04 Million |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $1.53 Million | -361.86% | 1.36x | $4.88 Million |
| Allurion Technologies, Inc. (ALUR) | $-32.31 Million | 0.00% | 0.00x | $1.19 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.16 Million |
| Artivion Inc (AORT) | $79.80 Million | -34.79% | 0.33x | $1.16 Billion |
| Apyx Medical Inc (APYX) | $2.22 Million | 4.46% | 0.72x | $127.64 Million |
About Pulsenmore Ltd. Ordinary Shares
Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products. The company was incorporated in 2014 and is based in Omer, Israel.